Is a complete TELA research report available?

No complete published report is available for TELA Bio, Inc. (TELA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

TELA Bio, Inc. (TELA)

NASDAQ: TELA · USD

$0.71

+0.03 (+4.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TELA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	31.8M
Revenue (ttm)	80.8M
Net income (ttm)	-39.8M
EPS (ttm)	-$0.80
Shares out	44.8M
Volume	55,836
Beta	1.34
Price target	$2.25	+217.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 80.8M
Net income (ttm): -39.8M
EPS (ttm): -$0.80
Market cap: 31.8M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All TELA indicators

Market & fundamental data

Available fields

207

Groups with data

Currency

USD

Showing 207 of 207 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001561921
Company name	TELA Bio, Inc.
Country	United States
Country code	US
Cusip	872381108
Employees	218
Employees Change	9%
Employees Change Percent	4.31
Enterprise value	$50M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	41
Industry PE Fwd	20.95
IPO Date	2019-11-08
Isin	US8723811084
Last refreshed	2026-07-31
Market cap	$31.8M
Market cap category	Nano-Cap
Price	$0.71
Price currency	USD
Rev Per Employee	370,706.42x
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	3841
Symbol	TELA
Website	https://www.telabio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-125.38%
EV Sales Forward	0.56x
EV/Sales	0.62x
FCF yield	-95.04%
P/S ratio	0.39x
PS Forward	0.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-41.84%
EBITDA Margin	-40.59%
Gross margin	67.72%
Gross Profit	$54.7M
Gross Profit Growth	13.91%
Gross Profit Growth Q	0.06%
Gross Profit Growth3 Y	21.17%
Gross Profit Growth5 Y	33.72%
Net Income	$-39.8M
Net Income Growth Years	0%
Pretax Margin	-49%
Profit Margin	-49.3%
Profit Per Employee	$-182,752
ROA	-28.72
Roa5y	-31.33
ROCE	-64.94
ROE	-616.6
Roe5y	-203.6
ROIC	-37.13

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-64.18%
Cagr3y	-57.83%
Cagr5y	-45.77%
EPS Growth Quarters	1
EPS Growth Years	3
Revenue Growth	13.48x
Revenue Growth Q	2.91x
Revenue Growth Quarters	27x
Revenue Growth Years	8x
Revenue Growth3 Y	21.46x
Revenue Growth5 Y	31.74x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.1
Assets	$69.9M
Cash	$39.5M
Current Assets	$64.3M
Current Liabilities	$17.8M
Debt	$57.8M
Equity	$-5.2M
Interest Coverage	-5.56
Liabilities	$75.1M
Long Term Assets	$5.6M
Long Term Liabilities	$57.3M
Net Cash	$-18.2M
Net Cash By Market Cap	$-57.42
Tangible Book Value	$-6.5M
Tangible Book Value Per Share	$-0.14
WACC	9.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.61
Inventory Turnover	2.03
Net Working Capital	$7.5M
Quick ratio	2.76
Working Capital	$46.5M
Working Capital Turnover	$1.62

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-48.21%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-64.15%
200-day SMA	0.94
3Y total return	-92.5%
50-day SMA	0.81
50-day SMA vs 200-day SMA	50under200
5Y total return	-95.31%
All Time High	23.55
All Time High Change	-96.99%
All Time High Date	2020-06-19
All Time Low	0.5
All Time Low Change	41.65%
All Time Low Date	2026-04-02
ATR	0.08
Beta	1.34
Beta1y	1.4
Beta2y	0.62
Ch YTD	-39.85
High	0.72
High52	2.14
High52 Date	2025-08-11
High52ch	-66.83%
Low	0.68
Low52	0.5
Low52 Date	2026-04-02
Low52ch	41.65%
Ma50ch	-12.32%
Price vs 200-day SMA	-24.61%
RSI	45
RSI Monthly	31.39
RSI Weekly	41.79
Sharpe ratio	-0.8x
Sortino ratio	-1.08
Total Return	-48.21%
Tr YTD	-39.85
Tr1m	-2.85%
Tr1w	-0.17%
Tr3m	-17.47%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	0
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.18
Earnings Revenue Estimate	20,006,720x
Earnings Revenue Estimate Growth	-0.94x
Operating Income	$-33.8M
Operating margin	-41.84
Price target	$2.25
Price Target Change	$217

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,931,212%
Float Percent	44.52%
Net Borrowing	17,580,000
Shares Insiders	7.63%
Shares Institutions	22.66%
Shares Out	44,766,146
Shares Qo Q	10.78%
Shares Yo Y	48.21%
Short Float	1.82%
Short Ratio	3.61
Short Shares	0.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-33.8M
Adjusted OCF	-33,232,000
Average Volume	54,035.25x
Bv Per Share	-0.12
CAPEX	$-535,000
Ch1m	-2.85
Ch1w	-0.17
Ch1y	-64.15
Ch3m	-17.47
Ch3y	-92.5
Ch5y	-95.31
Ch6m	-26.92
Change	4.77%
Change From Open	2.69
Close	0.68
Days Gap	2.02
Depreciation Amortization	1,007,000
Dollar Volume	39,632.4
Earnings Date	2026-08-10
Earnings Time	amc
EBIT	$-33.8M
EBITDA	$-32.8M
EPS	$-0.8
F Score	3
FCF	$-30.2M
FCF EV Yield	-60.37x
FCF Per Share	$-0.67
Financing CF	25,568,000
Fiscal Year End	December
Founded	2,012
Income Tax	$238,000
Investing CF	898,000
Ipr	-94.54
Iprfo	-94.84
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-25
Ma150	0.84
Ma150ch	-15.67%
Ma20	0.75
Ma20ch	-5.51%
Net CF	-3,307,000
Next Earnings Date	2026-08-10
Open	0.69
Optionable	Yes
Position In Range	72.83
Ppne	3,599,000
Price Date	2026-07-30
Relative Volume	1.04x
Revenue	80,814,000x
SBC By Revenue	4.42x
Share Based Comp	3,568,000
Tax By Revenue	0.29x
Tr6m	-26.92%
Us State	Pennsylvania
Volume	55,836
Z Score	-7.42

TELA Bio, Inc. (TELA)

Coverage state: Market snapshot only — no published research

Generate the first TELA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · TELA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TELA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TELA

Frequently asked questions